中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
The Chinese Journal of Clinical Pharmacology
2015年
18期
1852-1854,1862
,共4页
赤芍总苷%非小细胞肺癌%多药耐药基因1%多药耐药相关蛋白%肺耐药蛋白
赤芍總苷%非小細胞肺癌%多藥耐藥基因1%多藥耐藥相關蛋白%肺耐藥蛋白
적작총감%비소세포폐암%다약내약기인1%다약내약상관단백%폐내약단백
total paeony glycoside%non-small cell lung cancer%multidrug resistance gene 1%multidrug-associated protein%lung resistance protein
目的:探讨赤芍总苷对非小细胞肺癌模型大鼠 MDR1-mRNA、MRP-mRNA及LRP-mRNA基因表达影响效果。方法取50只雄性大鼠随机分为正常组5只,给予0.9%氯化钠;剩下45只大鼠分别构建鳞状细胞癌、腺癌、大细胞癌肺癌模型各15只,各模型构建成功后分别分为模型组、赤芍总苷组和环磷酰胺组,每组各5只。模型组背静脉注射0.9%氯化钠1 mL;赤芍总苷组每天背静脉注射赤芍总苷240 mg · kg-1;环磷酰胺组每天背静脉注射环磷酰胺0.4 mL· kg-1,各组均连续治疗7 d。试验结束后,处死各组大鼠,并取尾静脉血及肺组织,进行肿瘤标记物、白细胞水平检测,制备肺组织切片,并通过聚合酶链反应法检测MDR1-mRNA、MRP-mRNA及LRP-mRNA基因表达水平。结果赤芍总苷组和环磷酰胺组大鼠与模型组相比,癌胚抗原、糖蛋白抗原50水平、白细胞水平和白细胞最低值均有不同程度降低,其中赤芍总苷组癌胚抗原、糖蛋白抗原50水平显著低于环磷酰胺组( P<0.05),而赤芍总苷组白细胞和白细胞最低值较环磷酰胺组明显增高( P<0.05)。赤芍总苷组MDR1基因、MRP基因和LRP基因较环磷酰胺组表达量均明显增加( P<0.05)。结论赤芍总苷能够明显抑制肿瘤细胞,并降低肺耐药蛋白及多药耐药基因的表达,从而提高机体对药物的耐受性和敏感性。
目的:探討赤芍總苷對非小細胞肺癌模型大鼠 MDR1-mRNA、MRP-mRNA及LRP-mRNA基因錶達影響效果。方法取50隻雄性大鼠隨機分為正常組5隻,給予0.9%氯化鈉;剩下45隻大鼠分彆構建鱗狀細胞癌、腺癌、大細胞癌肺癌模型各15隻,各模型構建成功後分彆分為模型組、赤芍總苷組和環燐酰胺組,每組各5隻。模型組揹靜脈註射0.9%氯化鈉1 mL;赤芍總苷組每天揹靜脈註射赤芍總苷240 mg · kg-1;環燐酰胺組每天揹靜脈註射環燐酰胺0.4 mL· kg-1,各組均連續治療7 d。試驗結束後,處死各組大鼠,併取尾靜脈血及肺組織,進行腫瘤標記物、白細胞水平檢測,製備肺組織切片,併通過聚閤酶鏈反應法檢測MDR1-mRNA、MRP-mRNA及LRP-mRNA基因錶達水平。結果赤芍總苷組和環燐酰胺組大鼠與模型組相比,癌胚抗原、糖蛋白抗原50水平、白細胞水平和白細胞最低值均有不同程度降低,其中赤芍總苷組癌胚抗原、糖蛋白抗原50水平顯著低于環燐酰胺組( P<0.05),而赤芍總苷組白細胞和白細胞最低值較環燐酰胺組明顯增高( P<0.05)。赤芍總苷組MDR1基因、MRP基因和LRP基因較環燐酰胺組錶達量均明顯增加( P<0.05)。結論赤芍總苷能夠明顯抑製腫瘤細胞,併降低肺耐藥蛋白及多藥耐藥基因的錶達,從而提高機體對藥物的耐受性和敏感性。
목적:탐토적작총감대비소세포폐암모형대서 MDR1-mRNA、MRP-mRNA급LRP-mRNA기인표체영향효과。방법취50지웅성대서수궤분위정상조5지,급여0.9%록화납;잉하45지대서분별구건린상세포암、선암、대세포암폐암모형각15지,각모형구건성공후분별분위모형조、적작총감조화배린선알조,매조각5지。모형조배정맥주사0.9%록화납1 mL;적작총감조매천배정맥주사적작총감240 mg · kg-1;배린선알조매천배정맥주사배린선알0.4 mL· kg-1,각조균련속치료7 d。시험결속후,처사각조대서,병취미정맥혈급폐조직,진행종류표기물、백세포수평검측,제비폐조직절편,병통과취합매련반응법검측MDR1-mRNA、MRP-mRNA급LRP-mRNA기인표체수평。결과적작총감조화배린선알조대서여모형조상비,암배항원、당단백항원50수평、백세포수평화백세포최저치균유불동정도강저,기중적작총감조암배항원、당단백항원50수평현저저우배린선알조( P<0.05),이적작총감조백세포화백세포최저치교배린선알조명현증고( P<0.05)。적작총감조MDR1기인、MRP기인화LRP기인교배린선알조표체량균명현증가( P<0.05)。결론적작총감능구명현억제종류세포,병강저폐내약단백급다약내약기인적표체,종이제고궤체대약물적내수성화민감성。
Objective To explore the effection of total paeony glycosides on the expression of multidrug resistance gene in non -small cell lung cancer model rats.Methods Fifty male selected rats were randomly di-vided into control group ( 5 rats and only inject saline ) and model group (45 rats).The model group included squamous cell carcinoma , adeno-carcinoma and large cell carcinoma cell line , and each model contained 15 rats, when the models successfully constructed , the rats were grouped into model group , total paeony glycoside group and cyclophosphamide group.The total paeony glycoside group was injected the drug everyday through dorsal vein 240 mg · kg -1 , the model group was given intrave-nous injection of saline 1 mL and cyclophosphamide group was 0.4 mL· kg-1 for 7 days.After experiments , all the rats were executed and the vein blood and lung tissue were sampled for marking tumors , blood testing , histological section and detecting the expression levels of multidrug resistance gene 1-mRNA(MRP-mRNA), lung resistance protein -mRNA(LRP-mRNA) and multidrug resistance associated protein -mRNA ( MDR1 -mRNA ) gene by RT -PCR.Results Compared with the control group, carcino-embryonic antigen(CEA), CA50 level, white blood cell(WBC), and the minimum value of WBC all decreased to some extent in the total paeony glycoside group and cyclophosphamide group of these , the value of CEA , tumor marker 50(CA50) in total paeony glycoside group was significantly lower than values in cyclophosphamide group (P<0.05).While the minimum value of WBC was the opposite (P<0.05).Drug resistant gene in total paeony gly-coside group and cyclophosphamide group were all expressed to varying degrees , but polymerase chain reaction (PCR) product density , MDR1, MRP, and LRP gene expression in the former group all increased and larger than later group (P<0.05).Conclusion Total paeony glycoside can obviously inhibit the diffusion of tumor cells , the expression of lung resistant protein and multi -drug resistant gene , thereby enhancing the resistance and sensitivity of body to drug-sithas instructional significance for clinic .